Institution · Organix (United States)
Most cited papers from Organix (United States)
What are the most cited papers from Organix (United States)?
The most cited paper from Organix (United States) is "Cannabidiol displays unexpectedly high potency as an antagonist of CB 1 and CB 2 receptor agonists in vitro" (Adèle Thomas, Gemma L. Baillie, Angela M. Phillips et al., 2007), with 761 citations. Next come "A biosynthetic pathway for anandamide" (474) and "Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs" (413).
Showing 50 of 60 papers. Every paper with more than 44 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Cannabidiol displays unexpectedly high potency as an antagonist of CB 1 and CB 2 receptor agonists in vitro Adèle Thomas, Gemma L. Baillie, Angela M. Phillips et al. · British Journal of Pharmacology | 23 Jan 2007 | 761 |
| 2 | A biosynthetic pathway for anandamide Jie Liu, Lei Wang, Judith Dale Harvey-White et al. · Proceedings of the National Academy of Sciences | 28 Aug 2006 | 474 |
| 3 | Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs Billy R. Martin, David R. Compton, Brian F. Thomas et al. · Pharmacology Biochemistry and Behavior | Nov 1991 | 413 |
| 4 | 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) Analogues: A Promising Class of Monoamine Uptake Inhibitors Peter C. Meltzer, David Butler, Jeffrey R. Deschamps et al. · Journal of Medicinal Chemistry | 25 Jan 2006 | 412 |
| 5 | Multiple pathways involved in the biosynthesis of anandamide Jie Liu, Lei Wang, Judith Dale Harvey-White et al. · Neuropharmacology | 7 Jun 2007 | 309 |
| 6 | Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor László Offertáler, Fong-Ming Mo, Sándor Bátkai et al. · Molecular Pharmacology | 27 Feb 2003 | 229 |
| 7 | CB 1 cannabinoid receptor‐mediated modulation of food intake in mice Jenny L. Wiley, James J. Burston, Darnica C Leggett et al. · British Journal of Pharmacology | 21 Mar 2005 | 219 |
| 8 | Discovery and characterization of endogenous cannabinoids Billy R. Martin, Raphael Mechoulam, R K Razdan · Life Sciences | Jul 1999 | 204 |
| 9 | Cannabinoid CB 2 Receptor Activation Decreases Cerebral Infarction in a Mouse Focal Ischemia/Reperfusion Model Ming Zhang, Billy R. Martin, Martin W. Adler et al. · Journal of Cerebral Blood Flow & Metabolism | 24 Jan 2007 | 166 |
| 10 | Further Evidence of Dopamine Transporter Dysregulation in ADHD: A Controlled PET Imaging Study Using Altropane Thomas J. Spencer, Joseph Biederman, Bertha Kalifon Madras et al. · Biological Psychiatry | 25 May 2007 | 149 |
| 11 | Substituted 3-phenyltropane analogs of cocaine: synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging Peter C. Meltzer, A. Y. Liang, A.-L. Brownell et al. · Journal of Medicinal Chemistry | Apr 1993 | 138 |
| 12 | The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model Sudeshna Ghosh, Laura E. Wise, Yugang Chen et al. · Life Sciences | 28 Jun 2012 | 127 |
| 13 | Development of the first potent and specific inhibitors of endocannabinoid biosynthesis Tiziana Bisogno, Maria Grazia Cascio, Bijali Saha et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 24 Jan 2006 | 125 |
| 14 | Highly Selective CB1 Cannabinoid Receptor Ligands and Novel CB1/VR1 Vanilloid Receptor “Hybrid” Ligands Vincenzo Di Marzo, Tiziana Bisogno, Luciano De Petrocellis et al. · Biochemical and Biophysical Research Communications | Feb 2001 | 119 |
| 15 | Modulation of the balance between cannabinoid CB1 and CB2 receptor activation during cerebral ischemic/reperfusion injury M. Zhang, Billy R. Martin, Martin W. Adler et al. · Neuroscience | 26 Jan 2008 | 117 |
| 16 | Rapid detection of Parkinson's disease by SPECT with altropane: A selective ligand for dopamine transporters Alan J. Fischman, Ali A. Bonab, John W. Babich et al. · Synapse | Jun 1998 | 116 |
| 17 | Cardiovascular Effects of 2-Arachidonoyl Glycerol in Anesthetized Mice Zoltán Járai, Jens A. Wagner, Sravan Kumar Goparaju et al. · Hypertension | Feb 2000 | 102 |
| 18 | Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2‐arachidonoylglycerol Nazdar Ghafouri, Gunnar Tiger, Raj K. Razdan et al. · British Journal of Pharmacology | Nov 2004 | 102 |
| 19 | Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke Ming Zhang, Billy R. Martin, Martin W. Adler et al. · Journal of Neuroimmune Pharmacology | 2 Mar 2009 | 101 |
| 20 | The psychoactive plant cannabinoid, Δ 9 ‐tetrahydrocannabinol, is antagonized by Δ 8 ‐ and Δ 9 ‐tetrahydrocannabivarin in mice in vivo Roger G. Pertwee, Adèle Thomas, Leslie A. Stevenson et al. · British Journal of Pharmacology | 23 Jan 2007 | 99 |
| 21 | The Discovery of an Unusually Selective and Novel Cocaine Analog: Difluoropine. Synthesis and Inhibition of Binding at Cocaine Recognition Sites Peter C. Meltzer, A. Y. Liang, Bertha Kalifon Madras · Journal of Medicinal Chemistry | Jun 1994 | 95 |
| 22 | The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects Steven G. Kinsey, Anu Mahadevan, Bingjun Zhao et al. · Neuropharmacology | 17 Sep 2010 | 94 |
| 23 | Inhibition of Monoacylglycerol Lipase Attenuates Nonsteroidal Anti-Inflammatory Drug-Induced Gastric Hemorrhages in Mice Steven G. Kinsey, Daniel K. Nomura, Scott T. O’Neal et al. · Journal of Pharmacology and Experimental Therapeutics | 10 Jun 2011 | 91 |
| 24 | Structure−Activity Analysis of Anandamide Analogs: Relationship to a Cannabinoid Pharmacophore Brian F. Thomas, Irma B. Adams, S. Wayne Mascarella et al. · Journal of Medicinal Chemistry | 1996 | 88 |
| 25 | G Protein-coupled Endothelial Receptor for Atypical Cannabinoid Ligands Modulates a Ca2+-dependent K+ Current Malcolm Begg, Fong-Ming Mo, László Offertáler et al. · Journal of Biological Chemistry | Nov 2003 | 86 |
| 26 | Targeting multiple cannabinoid anti‐tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer Ryuichi Murase, Rumi Kawamura, Eric A. Singer et al. · British Journal of Pharmacology | 9 Jun 2014 | 84 |
| 27 | Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide Vincenzo Di Marzo, Christopher S. Breivogel, Tiziana Bisogno et al. · European Journal of Pharmacology | Oct 2000 | 81 |
| 28 | SAR of psilocybin analogs: Discovery of a selective 5-HT2C agonist Howard Sard, Govindaraj Kumaran, Cynthia Morency et al. · Bioorganic & Medicinal Chemistry Letters | 3 Aug 2005 | 80 |
| 29 | 2-Carbomethoxy-3-aryl-8-oxabicyclo[3.2.1]octanes: Potent Non-Nitrogen Inhibitors of Monoamine Transporters Peter C. Meltzer, Anna Y. Liang, Paul Blundell et al. · Journal of Medicinal Chemistry | Aug 1997 | 80 |
| 30 | Inhibition of Cytosolic Phospholipase A2α: Hit to Lead Optimization John C. McKew, Megan A. Foley, Paresh Thakker et al. · Journal of Medicinal Chemistry | 8 Dec 2005 | 77 |
| 31 | 6ʺ-Azidohex-2ʺ-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist Adèle Thomas, Ruth A. Ross, Bijali Saha et al. · European Journal of Pharmacology | 11 Feb 2004 | 77 |
| 32 | Asexual Populations of the Human Malaria Parasite, Plasmodium falciparum, Use a Two-Step Genomic Strategy to Acquire Accurate, Beneficial DNA Amplifications Jennifer L. Güler, D.L. Freeman, Vida Ahyong et al. · PLoS Pathogens | 23 May 2013 | 77 |
| 33 | A general method for C3 reductive alkylation of indoles Anu Mahadevan, Howard Sard, Mario Daniel Gonzalez et al. · Tetrahedron Letters | 19 May 2003 | 71 |
| 34 | A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2‐arachidonoylglycerol with potential anti‐obesity effects Tiziana Bisogno, Anu Mahadevan, Roberto Coccurello et al. · British Journal of Pharmacology | 17 Oct 2012 | 71 |
| 35 | Novel Cannabinol Probes for CB1 and CB2 Cannabinoid Receptors Anu Mahadevan, Craig Siegel, Billy R. Martin et al. · Journal of Medicinal Chemistry | 9 Sep 2000 | 71 |
| 36 | Pharmacological and behavioral evaluation of alkylated anandamide analogs Irma B. Adams, William J. Ryan, Michael I. Singer et al. · Life Sciences | May 1995 | 70 |
| 37 | Technepine: A high-affinity99mtechnetium probe to label the dopamine transporter in brain by SPECT imaging Bertha Kalifon Madras, Alun Gwynne Jones, Ashfaq Mahmood et al. · Synapse | Mar 1996 | 68 |
| 38 | New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis Alessia Ligresti, Maria Grazia Cascio, Gareth Pryce et al. · British Journal of Pharmacology | 14 Nov 2005 | 66 |
| 39 | O‐1057, a potent water‐soluble cannabinoid receptor agonist with antinociceptive properties Roger G. Pertwee, Thomas M. Gibson, Lesley Stevenson et al. · British Journal of Pharmacology | Apr 2000 | 65 |
| 40 | Sensitivity to Δ9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2−/− mice Christopher S. Breivogel, Jonathan M. Lambert, Steven Gerfin et al. · Behavioural Pharmacology | Jul 2008 | 62 |
| 41 | Nitrogen-based drugs are not essential for blockade of monoamine transporters Bertha Kalifon Madras, Zdenek B. Pristupa, Hyman B. Niznik et al. · Synapse | Dec 1996 | 62 |
| 42 | Potent Anandamide Analogs: The Effect of Changing the Length and Branching of the End Pentyl Chain William J. Ryan, W. Kenneth Banner, Jenny L. Wiley et al. · Journal of Medicinal Chemistry | Oct 1997 | 61 |
| 43 | 2-Carbomethoxy-3-aryl-8-bicyclo[3.2.1]octanes: Potent Non-Nitrogen Inhibitors of Monoamine Transporters Peter C. Meltzer, Paul Blundell, Yaw Fui Yong et al. · Journal of Medicinal Chemistry | 15 Jul 2000 | 59 |
| 44 | Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception Lamont Booker, Pattipati S. Naidu, Raj K. Razdan et al. · Drug and Alcohol Dependence | 13 Aug 2009 | 59 |
| 45 | [11C,127I] Altropane: A highly selective ligand for PET imaging of dopamine transporter sites Alan J. Fischman, Ali A. Bonab, John W. Babich et al. · Synapse | 2001 | 59 |
| 46 | Structural determinants of the partial agonist‐inverse agonist properties of 6′‐azidohex‐2′‐yne‐Δ8‐tetrahydrocannabinol at cannabinoid receptors Ruth A. Ross, Thomas M. Gibson, Lesley Stevenson et al. · British Journal of Pharmacology | Oct 1999 | 58 |
| 47 | Evaluation of Cannabimimetic Discriminative Stimulus Effects of Anandamide and Methylated Fluoroanandamide in Rhesus Monkeys Jenny L. Wiley, Keith M. Golden, William J. Ryan et al. · Pharmacology Biochemistry and Behavior | Dec 1997 | 54 |
| 48 | Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain Bertha Kalifon Madras, Lawrence M. Gracz, Michele A. Fahey et al. · Synapse | Jun 1998 | 54 |
| 49 | A Technetium-99m SPECT Imaging Agent Which Targets the Dopamine Transporter in Primate Brain Peter C. Meltzer, Paul Blundell, Alun Gwynne Jones et al. · Journal of Medicinal Chemistry | Jun 1997 | 54 |
| 50 | SR-141716A-induced stimulation of locomotor activity Caroline E. Bass, Graeme Griffin, Mark C. Grier et al. · Pharmacology Biochemistry and Behavior | 30 Oct 2002 | 52 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.